# FDA recall D-0559-2023

> **PD-Rx Pharmaceuticals, Inc.** · Class II · drug recall initiated 2023-04-06.

## Product

Glimepiride USP, 4 mg, 90 count-bottles, Rx only, Intas Pharm. Limited Pkg By: PD-Rx Pharmaceuticals Incorporated Oklahoma City, OK 73127, NDC 43063-0587-90

## Reason for recall

CGMP deviations.

## Distribution

Nationwide in the US.

## Key facts

- **Recall number:** D-0559-2023
- **Recalling firm:** PD-Rx Pharmaceuticals, Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2023-04-06
- **Report date:** 2023-05-10
- **Termination date:** 2024-04-30

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Oklahoma City, OK, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0559-2023

## Citation

> AI Analytics. FDA recall D-0559-2023. Retrieved 2026-06-09 from https://api.ai-analytics.org/recall/D-0559-2023. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*